88 related articles for article (PubMed ID: 15702357)
21. Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI.
Ross BD; Chenevert TL; Garwood M; Kim B; Stegman LD; Ben-Yoseph O; Zwolshen J; Rehemtulla A; Sunkara PS
NMR Biomed; 2003 Apr; 16(2):67-76. PubMed ID: 12730947
[TBL] [Abstract][Full Text] [Related]
22. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
[TBL] [Abstract][Full Text] [Related]
23. A model for evaluating therapeutic response of combined cancer treatment modalities: applied to treatment of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and 60Co-gamma radiation (RT).
Persson BR; Bauréus Koch C; Grafstrom G; Engstrom PE; Salford LG
Technol Cancer Res Treat; 2003 Oct; 2(5):459-70. PubMed ID: 14529312
[TBL] [Abstract][Full Text] [Related]
24. New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery.
Carson BS; Wu Q; Tyler B; Sukay L; Raychaudhuri R; DiMeco F; Clatterbuck RE; Olivi A; Guarnieri M
J Neurooncol; 2002 Nov; 60(2):151-8. PubMed ID: 12635662
[TBL] [Abstract][Full Text] [Related]
25. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
Yang W; Barth RF; Wu G; Ciesielski MJ; Fenstermaker RA; Moffat BA; Ross BD; Wikstrand CJ
Clin Cancer Res; 2005 Jan; 11(1):341-50. PubMed ID: 15671565
[TBL] [Abstract][Full Text] [Related]
26. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
Tzeng JJ; Barth RF; Orosz CG; James SM
Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
[TBL] [Abstract][Full Text] [Related]
27. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
28. Bromophenol blue staining of tumors in a rat glioma model.
Ozawa T; Britz GW; Kinder DH; Spence AM; VandenBerg S; Lamborn KR; Deen DF; Berger MS
Neurosurgery; 2005 Nov; 57(5):1041-7; discussion 1041-7. PubMed ID: 16284574
[TBL] [Abstract][Full Text] [Related]
29. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
[TBL] [Abstract][Full Text] [Related]
30. [Meningeal gliomatosis: development of experimental models].
Yoshida T; Ushio Y; Hayakawa T; Arita N; Yamada K; Mogami H
No Shinkei Geka; 1984 Sep; 12(10):1141-8. PubMed ID: 6504251
[TBL] [Abstract][Full Text] [Related]
31. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
32. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
[TBL] [Abstract][Full Text] [Related]
33. Experimental murine models of brainstem gliomas.
Ni S; Chen R; Hu K
Drug Discov Today; 2022 May; 27(5):1218-1235. PubMed ID: 34954326
[TBL] [Abstract][Full Text] [Related]
34. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
[TBL] [Abstract][Full Text] [Related]
35. Section on tumors: Young Investigator Award: Local release of carboplatin via an Alzet mini-osmotic pump prolongs survival in a rat brainstem tumor model.
Wu Q; Guarnieri M; Tyler B; Clatterbuck RE; Liu Y; Carson BS
Clin Neurosurg; 2004; 51():332-9. PubMed ID: 15571163
[No Abstract] [Full Text] [Related]
36. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.
Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL
Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746
[TBL] [Abstract][Full Text] [Related]
37. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
38. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
40. Development of a xenograft glioma model in mouse brain.
Kaye AH; Morstyn G; Gardner I; Pyke K
Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]